Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Feb 2022

Zinatizadeh Mohammad Reza, Zarandi Peyman Kheirandish, Zinatizadeh Maryam, Yousefi Mohammad Hadi, Amani Jaffar, Rezaei Nima

Abstract excerpt

Coronavirus disease 2019 (COVID-19) has a devastating impact on global populations triggered by a highly infectious viral sickness, produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The third major cause of mortality in the United States, following heart disease and cancer in 2020, was undoubtedly COVID-19. The centers for disease control and prevention (CDC) and the world health...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Vectors
Share to Angiotensin-Converting Enzyme 2

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to COVID-19

Share to COVID-19 Vaccines

Share to Genetic Variation

Share to SARS-CoV-2

Share to Treatment Outcome

Share to Vaccines, Synthetic

Source

Open in PubMed Open full text

Identifiers

PMID: 34906769
DOI: 10.1016/j.biopha.2021.112527
PMCID: PMC8660177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.PMID 34906769Read ↗

Vaccines against COVID-19: Priority to mRNA-Based FormulationsSemantic proximity Read ↗

Development of mRNA Vaccines/Therapeutics and Their Delivery SystemSemantic proximity Read ↗

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in miceSemantic proximity Read ↗

Immunogenicity and efficacy of Ad26. COV2 .S: An adenoviral vector–based COVID ‐19 vaccineSemantic proximity Read ↗

mRNA-based modalities for infectious disease managementSemantic proximity Read ↗

Long-term safety and efficacy of COVE study open-label and booster phasesSemantic proximity Read ↗

Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19Semantic proximity Read ↗

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine DevelopmentSemantic proximity Read ↗

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying MechanismSemantic proximity Read ↗

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination ArenaSemantic proximity Read ↗

Antigen Presentation of mRNA Based and Viral Vector Corona VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.